Medicofarma Biotech SA (WSE:MDB)
Poland
· Delayed Price · Currency is PLN 0.478
-0.008 (-1.65%)
At close: Apr 28, 2026
Medicofarma Biotech Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0 | 0.01 | 0.01 | 0.51 | 0.08 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0.01 | 0.01 | 0.51 | 0.08 | Upgrade
|
| Cash Growth | -72.08% | 19.22% | -98.97% | 556.50% | 20.91% | Upgrade
|
| Accounts Receivable | 1.45 | 0.48 | 0.38 | 0.37 | 1.42 | Upgrade
|
| Other Receivables | 3.67 | 3.33 | 2.13 | 1.24 | 0.03 | Upgrade
|
| Receivables | 5.11 | 3.8 | 2.51 | 1.61 | 1.45 | Upgrade
|
| Inventory | - | 0 | 0 | 0.14 | 0.56 | Upgrade
|
| Total Current Assets | 5.11 | 3.81 | 2.52 | 2.26 | 2.08 | Upgrade
|
| Property, Plant & Equipment | 9.03 | 10.55 | 12.09 | 12.56 | 12.7 | Upgrade
|
| Other Intangible Assets | 0.05 | 0.1 | 0.15 | 1.54 | 1.98 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.24 | 0.21 | - | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | - | 0.01 | - | Upgrade
|
| Total Assets | 14.2 | 14.71 | 14.97 | 16.37 | 16.77 | Upgrade
|
| Accounts Payable | 1.22 | 1.29 | 1.19 | 1.34 | 1.47 | Upgrade
|
| Accrued Expenses | 0.48 | 1.56 | 2.26 | 1.11 | 0.44 | Upgrade
|
| Short-Term Debt | 0 | 0 | 0 | - | - | Upgrade
|
| Current Income Taxes Payable | 2.23 | 1.5 | 0.53 | 0.14 | 0.06 | Upgrade
|
| Other Current Liabilities | 0.15 | 0.13 | 0.04 | 0.69 | 0.12 | Upgrade
|
| Total Current Liabilities | 4.09 | 4.49 | 4.02 | 3.28 | 2.08 | Upgrade
|
| Long-Term Debt | 3.71 | 2.53 | 1.39 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.72 | 0.82 | 0.38 | 0.48 | 0.48 | Upgrade
|
| Total Liabilities | 8.52 | 7.84 | 5.8 | 3.76 | 2.56 | Upgrade
|
| Common Stock | 6.8 | 6.8 | 6.8 | 6.8 | 6.8 | Upgrade
|
| Additional Paid-In Capital | 8.95 | 8.95 | 8.95 | 8.95 | 8.95 | Upgrade
|
| Retained Earnings | -10.06 | -8.87 | -6.57 | -3.13 | -1.54 | Upgrade
|
| Shareholders' Equity | 5.68 | 6.87 | 9.18 | 12.61 | 14.2 | Upgrade
|
| Total Liabilities & Equity | 14.2 | 14.71 | 14.97 | 16.37 | 16.77 | Upgrade
|
| Total Debt | 3.71 | 2.53 | 1.39 | - | - | Upgrade
|
| Net Cash (Debt) | -3.71 | -2.53 | -1.39 | 0.51 | 0.08 | Upgrade
|
| Net Cash Growth | - | - | - | 556.50% | - | Upgrade
|
| Net Cash Per Share | -0.05 | -0.04 | -0.02 | 0.01 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 | Upgrade
|
| Total Common Shares Outstanding | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 | Upgrade
|
| Working Capital | 1.02 | -0.68 | -1.5 | -1.01 | -0 | Upgrade
|
| Book Value Per Share | 0.08 | 0.10 | 0.13 | 0.19 | 0.21 | Upgrade
|
| Tangible Book Value | 5.64 | 6.78 | 9.02 | 11.08 | 12.22 | Upgrade
|
| Tangible Book Value Per Share | 0.08 | 0.10 | 0.13 | 0.16 | 0.18 | Upgrade
|
| Land | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | Upgrade
|
| Buildings | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 | Upgrade
|
| Machinery | 9.01 | 9.01 | 9.01 | 8.11 | 7.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.